Johnson & Johnson’s “bankruptcy”

Johnson & Johnson’s “bankruptcy”

Up next

Trump's human printer

Natalie Harp may be the most powerful executive assistant in the world, and her unusual relationship with her boss — the president — is getting a lot of attention. This episode was produced by Denise Guerra and Ariana Aspuru, edited by Jolie Myers, fact-checked by Gabriel Dunatov ...  Show more

Medicare for All fever

A new crop of Democrats is running on an old slogan: Medicare for All. Now might be the moment it finally catches on. This episode was produced by Peter Balonon-Rosen, edited by Jolie Myers, fact-checked by Gabriel Dunatov, engineered by Patrick Boyd and David Tatasciore, and hos ...  Show more

Recommended Episodes

Inside Johnson & Johnson’s bankruptcy two-step
The Story of Money

Johnson & Johnson, one of the world’s largest healthcare companies, is facing thousands of lawsuits from people alleging they got cancer from using one of their oldest products: talc-based baby powder. 


To manage the growing liability, J&J recently deplo ...

  Show more

How The Wealthiest Corporations Are Dodging Lawsuits Through Bankruptcy
Consider This from NPR

Thousands of people who claim Johnson & Johnson baby powder caused them to develop cancer cannot sue the company, which used a controversial legal maneuver in bankruptcy court to freeze lawsuits against it.NPR's Brian Mann explains. More from his reporting here. Additional report ...  Show more

Ep. 217: Discovery Debacle At Arnold & Porter
Law360's Pro Say - News & Analysis on Law and the Legal Industry

Endo Pharmaceuticals and its attorneys at Arnold & Porter are facing accusations of serious discovery misconduct during opioid litigation across the country, threatening the company with huge liability and the lawyers with reputational damage. On this week’s show, we break down t ...  Show more

J&J Attempts a “Texas Two-Step”
Motley Fool Hidden Gems Investing

Johnson & Johnson proposes a $9 billion settlement and Chewy hits a speedbump. (00:21) Dylan Lewis and Tim Beyers discuss: - The fallout from Johnson & Johnson's talc settlement. - What the lawsuit could mean for J&J's spinoffs. - Why the US Department of Justice is taking a look ...  Show more